https://clinicaltrials.gov/ct2/show/NCT04410978?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Condition : Relapsing Multiple Sclerosis
Interventions : Drug: SAR442168; Drug: Teriflunomide HMR1726; Drug: Placebo to match SAR442168; Drug: Placebo to match Teriflunomide
Sponsor : Sanofi
Not yet recruiting
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton’s Tyrosine Kinase (BTK) Inhibitor SAR442168
NCT04410978
Mon, 01 Jun 2020 12:00:00 EDT
First Added: 06/01/20 07:15AM
